Report

Cell & Gene Therapy Report

06.3.23 2 minute read

Our latest research report from our Life Sciences 2030 series explores the fastest growing area within the therapeutics market, Cell & Gene Therapy.

Cell and Gene therapies (CGT) are currently tipping the scales as the fastest growing area within the therapeutics market.

While the property sector has quickly absorbed and understood the broad spectrum of requirements of companies working across the various facets of CGT, it is clear demand will evolve and change over the coming years.

This report explores the evolution of CGT, market growth value, challenges, local considerations and real estate demands.

Download our Cell & Gene Therapy Report:

Enter details

Contributors:

Sue Foxley

Research Director

Get in touch

Sue Foxley

Research Director

Sue leads a dynamic programme of research at Bidwells. Working with her colleague Mark Callender, she is particularly focused on the real estate implications of the science and technology sector.

Max Bryan

Partner, Head of Laboratory & Office Agency

Max works with pioneering innovators and tech entrepreneurs, leading our unparalleled offices and labs agency team.

This paper has been written jointly with Tahrima Rahim, she is a Research Analyst at Ironstone Asset Management, the investment adviser to Life Science REIT.

Our Expertise

Related Services

Science & Technology

Find out more

Watch the video below

Credits: Bio-Innovation Centre, TusPark, Cambridge Science Park; Babraham Research Campus; Sherard Building, Oxford Science Park

Life Sciences 2030

We are witnessing an evolution of the life science sector both in the UK and internationally. Not only is the sector expanding rapidly but scientific developments are facilitating new techniques and product outputs.

Download our report

Cell & Gene Therapy Report